register

Human Resources

A Voice for health equity: Organon and J&J leaders champion the Voice to Parliament as a catalyst for change

Health Industry Hub | May 17, 2023 |

Human Resources: In a thought-provoking interview with Health Industry Hub, industry leaders from the pharma and medtech sectors shed light on the significance of the Voice to Parliament in closing the gap in health equity for Aboriginal and Torres Strait Islander peoples.

With the upcoming referendum on the Voice to Parliament, Meshlin Khouri, Associate Director of Policy and Communications at Organon and Deborah Guion, Head of Global Community Impact at Johnson & Jonson expressed their organisations’ commitment to educating and raising awareness among their employees about the referendum and its potential implications. They recognised the historic nature of this moment and acknowledged the Voice to Parliament as a critical step towards reconciliation and creating a more inclusive nation.

In addressing some of the misconceptions and myths surrounding the Voice to Parliament, Deb and Meshlin highlighted the importance of engaging in open and respectful dialogue with individuals who may hold different perspectives. They emphasised the need for active listening and understanding to address concerns and dispel myths surrounding the referendum.

Meshlin stressed the importance of addressing existing healthcare inequities, particularly for women, and how the Uluru statement from the Heart aligns with Organon’s commitment to inclusivity and addressing disparities.

Deb emphasised that as corporate citizens, Johnson & Johnson has a responsibility to equip their workforce with the necessary knowledge to make informed choices. Understanding the history, significance, and potential impact of the Voice, will contribute to a more equitable and inclusive healthcare system.

As the conversation drew to a close, both health leaders highlighted the significance of this moment in the nation’s history and the need for active participation and informed choices from all.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the ONLY one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The exclusive leadership and influencer podcasts and vodcasts add huge value to our breaking news coverage. The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - MedTech & Diagnostics

Government commissions review as 70% of private hospitals face financial crisis

Government commissions review as 70% of private hospitals face financial crisis

Health Industry Hub | June 14, 2024 |

MedTech & Diagnostics News: Despite playing a crucial role in providing acute care and surgical services, a staggering 70% of […]

More


News & Trends - Pharmaceuticals

Pharmacy Guild echoes ACCC red flags over Chemist Warehouse-Sigma deal

Pharmacy Guild echoes ACCC red flags over Chemist Warehouse-Sigma deal

Health Industry Hub | June 14, 2024 |

Pharma News: The Pharmacy Guild of Australia has echoed the significant concerns of the Australian Competition and Consumer Commission (ACCC) […]

More


News & Trends - MedTech & Diagnostics

Competition watchdog raises concerns over cancer care provider's expansion plans

Competition watchdog raises concerns over cancer care provider’s expansion plans

Health Industry Hub | June 14, 2024 |

MedTech & Diagnostics News: A leading provider of cancer care services in Australia, faces scrutiny from the Australian Competition and […]

More


News & Trends - Biotechnology

Aussie biotech secures first local CAR T patent

Aussie biotech secures first local CAR T patent

Health Industry Hub | June 13, 2024 |

Biotech News: A Melbourne-based biotechnology company which specialises in developing immune cell therapies for cancer treatment, has been granted its […]

More


This content is copyright protected. Please subscribe to gain access.